SELLAS Life Sciences Group, Inc.

SLS

NASDAQ

$ -

Review earnings summary, surprise history, and upcoming forecasts.

account_balance_walletEarnings Summary

Updated: 05/12/2026FY2026 Q1

Revenue (TTM)

0M USD

YoY -

Net Income (TTM)

-8M USD

YoY Expanded Deficit

Equity Ratio

94.1%

YoY +14.7pt

BPS

0.62$

YoY +96.9%

Revenue

FY2024 Q2$0

FY2024 Q3$0

FY2024 Q4$0

FY2025 Q1$0

FY2025 Q2$0

FY2025 Q3$0

FY2025 Q4$0

FY2026 Q1$0

Actual

YoY$0 (-)

Net Income

$-8.4M

FY2024 Q2$-17M

$-17M

FY2024 Q3$-24.1M

$-24.1M

Surprise History

Actual RevenueAnalyst Estimate

FY2021BEAT

Actual:$7.6M

Est:$5.1M

FY2021BEAT

$7.6M

Earnings Release History